Sun.Jul 14, 2024

article thumbnail

Have Fun in the Sun, But Protect Your Skin, Expert Says

Drugs.com

SUNDAY, July 14, 2024 — Roughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable.Skin cancer is not only the most common cancer, it's also the most preventable. Most of the time, too much sun e.

103
103
article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

LatinX@Broad Presents The René Salazar Speaker Series: Mariana Matus

Broad Institute

LatinX@Broad Presents The René Salazar Speaker Series: Mariana Matus By Rose Circeo July 14, 2024 Breadcrumb Home LatinX@Broad Presents The René Salazar Speaker Series: Mariana Matus Dr. Mariana Matus My Journey of spinning off my PhD research into a startup Learn more about the LatinX@Broad speaker series.

article thumbnail

Why Universal Design in Health Systems Matters for Inclusivity and Accessibility – 2

Perficient: Drug Development

Welcome to the second installment of our Universal Design and Health Systems blog series. Today, we will delve into why Universal Design is essential for fostering inclusivity and accessibility in health systems. As healthcare systems evolve, ensuring that facilities, services, and technologies are accessible to all individuals, regardless of their abilities, is crucial.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Where's the Synthetic Blood?

Codon

Dr. Keith Neeves gives a history of blood transfusions and explains why it will be difficult to scale up the creation of synthetic blood for Issue 03 of Asimov Press. We are mostly blood. Of the 36 trillion cells in the human body, 32 trillion are blood cells. These blood cells synchronize the delivery of oxygen to every tissue in your body, fight pathogens, and heal wounds.

article thumbnail

Why Universal Design in Health Systems Matters for Improved Patient Experience – 3

Perficient: Drug Development

Welcome to the third installment of our Universal Design and Health System blog series. In this edition, we explore why Universal Design is crucial for enhancing patient experience within healthcare environments. Universal Design principles aim to create spaces and services that are accessible, inclusive, and user-friendly for all individuals, regardless of their abilities or disabilities.

article thumbnail

DENODO: Data virtualization tool

Perficient: Drug Development

WHAT IS DENODO: The Denodo Platform is a data virtualization framework in the market that uses logical approach to enable self-service BI, data science, hybrid/multi-cloud data integration, and enterprise data services. Today, several large Fortune 1000 companies leverage Denodo to support their mission-critical data virtualization strategies. A single view of enriched and transformed data from multiple data stores.